Threshold Pharmaceuticals (THLD)
Add to Watchlists Create an Alert
5.445
-0.14 -2.42%
NASDAQ
May 22, 4:59PM
BATS Real time
Currency in USD
Threshold Pharmaceuticals Revenue Quarterly YoY Growth:
1060% for March 31, 2013Threshold Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1060% |
| Dec. 31, 2012 | 3160% |
| Sept. 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| Dec. 31, 2011 | |
| Sept. 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| Dec. 31, 2010 | |
| Sept. 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| Dec. 31, 2009 | -100.0% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
THLD Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Merrimack Pharmaceuticals | 12.83% |
| ZIOPHARM Oncology | 0.00% |
| Clovis Oncology |
THLD Revenue Quarterly YoY Growth Rankings
| Overall |
99th percentile 33 of 8005 |
| Sector |
97th percentile 15 of 686 in Healthcare |
| Industry |
96th percentile 8 of 248 in Biotechnology |
THLD Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -100.0% | Mar 2009 |
| Maximum | 3160% | Dec 2012 |
| Average | 424.5% |